A former synagogue president has won $120,000 in damages after suing The Age and two journalists over articles that accused him of unilaterally inviting a convicted spy to speak at an event.
An appeal against a ruling that the developer of a $55M Sunshine Coast residential complex could not set off a liquidated damages claim against builder Tomkins’ pre-completion payment claim has been thrown out.
A developer has won an extension of a freeze on $25 million held in escrow in its dispute with a builder over payment claims for a Main Beach high-rise, after it filed an appeal.
A life sciences and regulatory expert and her team have joined Thomson Geer following the shuttering of Hogan Lovells’ Australian practice.
After a spat over legal expenses in Bruce Lehrmann’s defamation case, and a final agreement to accept $1.15 million from Ten to cover the costs, presenter Lisa Wilkinson has lost her bid for more costs.
A judge has found a $3.7 million error by an adjudicator in a dispute over a $43 million payment claim for work on an apartment complex in Queensland’s Main Beach showed a failure to properly consider the evidence and submissions.
A judge has accepted Mitsubishi’s argument that an investigation into the fuel consumption of its Triton cars is protected by litigation privilege and should not be handed over to a class action.
The national operations manager at an Australian law firm has been struck from the roll for professional misconduct after a tribunal found she had a “pattern and history of dishonesty” while dealing with trust accounts.
Duke Ventures has succeeded in setting aside a statutory demand from the builder of a 10-storey development in Collingwood, with a judge finding the property developer can rely on a $6 million offsetting claim.
Australian cancer care company GenesisCare has been sued by Novartis unit Endocyte for allegedly infringing the patents for its prostate cancer treatment Pluvicto. The lawsuit, filed in the Federal Court in January, accuses GenesisCare of infringing or threatening to infringe patents held by Endocyte and Purdue Research Foundation by supplying lutetium, the generic version of…